Universitą degli studi di Pavia
Contenuto della pagina
prosperi pubblicazioni
1- PELLICCIARI C. and PROSPERI E. - Quantitative cytochemical study of chromatin during megakaryocyte maturation.
Bas. Appl. Histochem., 24, 409-421, 1980.
2- PROSPERI E. and RAAP A.K. - Substrate protection during the fixation of β-glucuronidase: cytochemical model system studies.
Histochem. J., 14, 689-692, 1982.
3- BOTTIROLI G., GIORDANO P. and PROSPERI E. - Fluorescent probes for nuclei acid research.
Acta Histochem., suppl. 26, 189-194, 1982.
4- PROSPERI E., RAAP A.K. and VAN DER PLOEG M. - Histochemical model studies of enzyme activity after thermal damage.
Histochemistry, 75, 387-397, 1982.
5- PROSPERI E., CROCE A.C., BOTTIROLI G. DASDIA T. and SUPINO R. - Uptake kinetics and intracellular distribution of anthracyclines studied by laser cytofluorometry.
Bas. Appl. Histochem., 27, 117-127, 1983.
7- GIORDANO P.A., PROSPERI E. and BOTTIROLI G. - Primary fluorescence of rat muscle after CO2 thermal injury.
Lasers Surg. Med., 4, 271-278, 1984.
7- PROSPERI E., CROCE A.C., BOTTIROLI G. and SUPINO R. - Influence of Daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein.
Chem.-Biol. Interactions, 54, 271-280, 1985.
8- PROSPERI E., CROCE A.C., BOTTIROLI G. and SUPINO R. - Flow cytometric analysis of membrane permeability properties influencing intracellular accumulation and efflux of fluorescein.
Cytometry, 7, 70-75, 1986.
9- SUPINO R., PROSPERI E., FORMELLI F., MARIANI M. and PARMIANI G. - Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.
Br. J. Cancer, 54, 33-42, 1986.
10- CROCE A.C., PROSPERI E., SUPINO R. and BOTTIROLI G. - Anthracycline-induced inhibition of membrane permeability functions dependent on metabolic energy.
Br. J. Cancer, 54, 943-950, 1986.
11- PROSPERI E., BOTTIROLI G. and SUPINO R. - Flow cytometric evaluation of DNA digestion with S1 nuclease.
Bas. Appl. Histochem., 31, 511-520, 1987.
12- SUPINO R., MARIANI M., PROSPERI E. and PARMIANI G. - Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iododoxorubicin.
Cancer Chemother. Pharmacol., 21, 251-254, 1988.
13- GIANGARE' M.C., PROSPERI E. and BOTTIROLI G. - DNA sensitivity to S1 nuclease detected by base-specific fluorochromes.
Bas. Appl. Histochem., 32, 297-299, 1988.
14- CROCE A.C., BOTTIROLI G., PROSPERI E., SUPINO R. and STOWARD P.J. - Limitations of the quantitative cytochemical assay of catechol oxidase in melanoma cells.
Histochem. J., 20, 595-602, 1988.
15- MARIANI M., PROSPERI E., COLOMBO A. and SUPINO R. - Doxorubicin resistance circumvention by verapamil in B16 melanoma cells.
Anticancer Res., 9, 29-32, 1989.
16- PROSPERI E., CROCE A.C., SUPINO R. and BOTTIROLI G. - Metabolic energy availability and proliferative activity in Adriamycin-treated cells.
Anticancer Res., 9, 203-208, 1989.
17- PRATESI G., MANZOTTI C., TORTORETO M., PROSPERI E. and ZUNINO F. - Effects of 5-FU and cis-DDP combination on human colorectal tumor xenografts.
Tumori, 75, 60-65, 1989.
18- GIANGARE' M.C., PROSPERI E., PEDRALI-NOY G. and BOTTIROLI G. - Flow cytometric evaluation of DNA stainability with Propidium Iodide after histone H1 extraction.
Cytometry, 10, 726-730, 1989.
19- PROSPERI E., GIANGARE' M.C., SUPINO R. and BOTTIROLI G. - Parameters influencing the flow cytometric analysis of DNA sensitivity to nuclease S1.
Histochemistry, 93, 417-421, 1990.
20- PROSPERI E. - Intracellular turnover of Fluorescein diacetate. Influence of membrane ionic gradient on Fluorescein efflux.
Histochem J., 22, 227-233, 1990.
21- PROSPERI E., GIANGARE' M.C., SUPINO R. and BOTTIROLI G. - Flow cytometric evaluation of DNA digestion with micrococcal nuclease on isolated HeLa nuclei.
J. Microsc., 159, 255-263, 1990.
22- PROSPERI E., GIANGARE' M.C. and BOTTIROLI G. - Nuclease-induced DNA structural changes assessed by flow cytometry with the intercalating dye Propidium Iodide.
Cytometry, 12, 323-329, 1991.
23- SUPINO R., MARIANI M., COLOMBO A., PROSPERI E., CROCE A.C. and BOTTIROLI G. - Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells.
Eur. J. Cancer, 28 A, 778-783, 1992.
24- BARNI S., NANO R., BERTONE V. and PROSPERI E. - Ultrastructure and cytochemistry of circulating erythrocytes during the annual cycle of Rana esculenta L..
Comp. Haematol. Intern., 2, 166-169, 1992.
25- PROSPERI E., SALA C., NEGRI C., OLIANI C., SUPINO R., ASTALDI RICOTTI G.B.C. and BOTTIROLI G. - Topoisomerase II and in human tumor cells grown in vitro and in vivo.
Anticancer Res., 12, 2093-2100, 1992.
26- PROSPERI E., SUPINO R. and BOTTIROLI G. - Increased sensitivity of damaged DNA to digestion with nuclease S1 as assessed in single cells by flow cytometry.
Cytometry, 14, 53-58, 1993.
27- PROSPERI E., STIVALA L.A. and BIANCHI L. - Flow cytometric analysis of DNA sensitivity to nuclease S1 in UVC-irradiated human fibroblasts.
J. Photochem. Photobiol. B: Biol., 18, 91-93, 1993.
28- PROSPERI E., STIVALA L.A., SALA E., SCOVASSI A.I. and BIANCHI L. - Proliferating cell nuclear antigen complex formation induced by ultraviolet irradiation in human quiescent fibroblasts as detected by immunostaining and flow cytometry.
Exp. Cell Res., 205, 320-325, 1993.
29- SUPINO R., BINASCHI M., CAPRANICO G., GAMBETTA R., PROSPERI E., SALA E. and ZUNINO F. - A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin.
Int. J. Cancer, 54, 309-314, 1993.
30- GIANGARE' M.C., PROSPERI E., MONTI E. and BOTTIROLI G.- Effects of isolation conditions on the cytometric evaluation of chromatin structure in rat myocardial nuclei.
Anal. Cell. Pathol., 5, 311-315, 1993.
31- STIVALA L.A., PROSPERI E., ROSSI R. and BIANCHI L. - Involvement of proliferating cell nuclear antigen in DNA repair after damage induced by genotoxic agents in human fibroblasts.
Carcinogenesis, 14, 2569-2573, 1993.
32- PARACCHINI L., JOTTI A., BOTTIROLI G., PROSPERI E., SUPINO R. and PICCININI F. - The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of Adriamycin while preserving the cytotoxic activity.
Anticancer Res., 13, 1607-1612, 1993.
33- BARNI S., NANO R., CAPELLI E., PROSPERI E. - Ultrastruttura e citofluorimetria della cinetica interattiva in vitro tra cellule LAK e cellule neoplastiche bersaglio.
Acta Gerontol., 43, 179-180, 1993.
34- PROSPERI E., NEGRI C., MARCHESE G. and ASTALDI RICOTTI G.C.B. - Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes.
Cell Prolif., 27, 257-267, 1994.
35- NANO R., BARNI S., CAPELLI E., CREMASCHI P., CATANESE C., TOMASELLI S., NASCIMBENE C. and PROSPERI E. - Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro.
Acta Oncol., 33, 165-169, 1994.
36- PROSPERI E., GIANGARE' M.C. and BOTTIROLI G. - DNA stainability with base-specific fluorochromes: dependence on the DNA topology in situ.
Histochemistry, 102, 123-128, 1994.
37- GUANO F., BERNARDI R., NEGRI C., DONZELLI M., PROSPERI E., ASTALDI RICOTTI G.C.B. and SCOVASSI A.I. - Dose-dependent zinc inhibition of DNA ladder in apoptotic HeLa cells regulates the activity of poly(ADP-ribose) polymerase and does not protect from death induced by VP-16.
Cell Death Differ., 1, 101-107, 1994.
38- PROSPERI E., SCOVASSI A.I., STIVALA L.A. and BIANCHI L. - Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. Exp. Cell Res., 215, 257-262, 1994.
39- NANO R., BARNI S., CAPELLI E., PROSPERI E., SALVUCCI O., ROSSI A., LAVEZZI L. - Cocultures of lymphokine-activated killer (Lak)-target cells: a cytokinetic study.
Med. Biol. Environ., 22, 341-346, 1994.
40- MONTI E., PROSPERI E., SUPINO R. and BOTTIROLI G. - Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by Adriamycin in the rat.
Anticancer Res., 15, 193-198, 1995.
41- NANO R., BARNI S., CAPELLI E., PROSPERI E., LAVEZZI L. and SALVUCCI O. - DNA-protein cell content of lymphokine activated killer (LAK) and target cells in coculture.
Anticancer Res., 15, 751-754, 1995.
42- BERNARDI R., NEGRI C., DONZELLI M., GUANO F., TORTI M., PROSPERI E. and SCOVASSI A.I. - Activation of poly(ADP-ribose)polymerase in apoptotic human cells.
Biochimie, 77, 378-384, 1995.
43- BINASCHI M., SUPINO R., GAMBETTA R., GIACCONE G., PROSPERI E., CAPRANICO G., CATALDO I. and ZUNINO F. - MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance.
Int. J. Cancer 62, 84-89, 1995.
44- STIVALA L.A., SCOVASSI A.I., BIANCHI L. and PROSPERI E. - Nuclear binding of cell cycle-related proteins: Cyclin A versus proliferating cell nuclear antigen (PCNA).
Biochimie 77, 888-892, 1995.
45- PROSPERI E., NEGRI C., BOTTIROLI G. and ASTALDI RICOTTI G.C.B. - Immunocytometric determination of the and isoforms of human DNA topoisomerase II: influence of different fixatives.
Anal. Cell. Pathol., 10, 137-148, 1996.
46- BARNI S., FRASCHINI A., PROSPERI E., VACCARONE R. and BERNINI F. - Possible occurrence of amitotic cell division during haemotopoiesis in the Urodeles.
Comp. Haematol. Int., 5, 183-188, 1996.
47- SAVIO M., STIVALA L.A., SCOVASSI A.I., BIANCHI L. and PROSPERI E. - p21waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites.
Oncogene 13, 1591-1598, 1996.
48- NEGRI C., BERNARDI R., DONZELLI M., PROSPERI E. and SCOVASSI A.I. -Sequence of events leading to apoptosis in long term cultured HeLa cells.
Cell Death Differ. 3, 425-430, 1996.
49- SUPINO R., RIGHETTI S., MAGNANI I., BOTTIROLI G. and PROSPERI E. - Modulation and cell cycle distribution of mutant p53 protein in a human small-cell lung carcinoma cell line.
Cell. Pharmacol. 3, 253-260, 1996.
50- STIVALA L.A., SAVIO M., CAZZALINI O., PIZZALA R., REHAK L., BIANCHI L., VANNINI V. and PROSPERI E. - Effect of β-carotene on cell cycle progression of human fibroblasts.
Carcinogenesis 17, 2395-2401, 1996.
51- TUPLER R., MARSEGLIA G., STEFANINI M., NARDO T., PROSPERI E., CHESSA L., MACCARIO R., MONTAGNA D., MARCHI A. and MARASCHIO P. - A Nijmegen breakage syndrome with unusual chromosome rearrangements.
J. Med. Genet. 34, 196-202, 1997.
52- PROSPERI E., STIVALA L.A., SCOVASSI A.I., and BIANCHI L. - Cyclins: relevance of subcellular localization in cell cycle control.
Eur. J. Histochem. 41, 161-168, 1997.
53- SCOVASSI A.I., STIVALA L.A., ROSSI L., BIANCHI L., and PROSPERI E. - Nuclear association of cyclin D1 in human fibroblasts: tight binding to nuclear structures and modulation by protein kinase inhibitors.
Exp. Cell Res. 237, 127-134, 1997.
54- DONZELLI M., NEGRI C., MANDARINO A., ROSSI L., PROSPERI E., FROUIN I., BERNARDI R., BURKLE A. and SCOVASSI A.I. - Poly(ADP-ribose) synthesis: a useful marker to identify apoptotic cells.
Histochem. J. 29, 831-837, 1997.
55- SAVIO M., STIVALA L.A., BIANCHI L., VANNINI V. and PROSPERI E. - Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts.
Carcinogenesis 19, 591-596, 1998.
56- ALESSI F., QUARTA S., SAVIO M., RIVA F., ROSSI L., STIVALA L.A., SCOVASSI A.I., MEIJER L. and PROSPERI E. - The cyclin-dependent kinase inhibitors olomucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Exp. Cell Res., 245, 8-18, 1998.
57- DONZELLI M., BERNARDI R., NEGRI C., PROSPERI E., PADOVAN L., LAVIALLE C., BRISON O. and SCOVASSI A.I. - Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
Oncogene 18, 439-448, 1999.
58- TORRIGLIA A., NEGRI C., CHAUDUN E., PROSPERI E., COURTOIS Y., COUNIS M.F. and SCOVASSI A.I. - Differential involvement of DNases in HeLa cell apoptosis induced by etoposide and long term-culture.
Cell Death Differ., 6, 234-244, 1999.
59- STIVALA L.A., SAVIO M., QUARTA S., SCOTTI C., CAZZALINI O., ROSSI L., SCOVASSI I.A., PIZZALA R., MELLI R., BIANCHI L., VANNINI V. and PROSPERI E. - The antiproliferative effect of -carotene requires p21waf1/cip1 in normal human fibroblasts.
Eur. J. Biochem., 267, 2290-2296, 2000.
60- RUMIO C., DONETTI E., IMBERTI A., BARAJON I., PROSPERI E., BRIVIO M.F., BOSELLI A., LAVEZZARI E., VERALDI S., BIGNOTTO M., CASTANO P. - c-Myc expression in human anagen hair follicles.
Br. J. Dermatol., 142, 1092-99, 2000
61- STIVALA L.A., RIVA F., CAZZALINI O., SAVIO M., PROSPERI E. – p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitmento of PCNA to repair sites.
Oncogene 20, 563-570, 2001
62- STIVALA L.A., SAVIO M., CARAFOLI F., PERUCCA P., BIANCHI L., MAGA G., FORTI L., PAGNONI U.M., ALBINI A., PROSPERI E., VANNINI V. – Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol.
J. Biol. Chem. 276, 22586-22594, 2001.
63- FROUIN I., PROSPERI E., DENEGRI M., NEGRI C., DONZELLI M., ROSSI L., RIVA F., STEFANINI M., SCOVASSI A.I.- Different effects of methotrexate on DNA mismatch repair proficient and deficient cells.
Eur. J. Cancer 37, 1173-1180, 2001.
64- MONTECUCCO A., ROSSI R., FERRARI G., SCOVASSI A.I., PROSPERI E., BIAMONTI G. – Etoposide induces the dispersal of DNA ligase I from replication factories.
Mol. Biol. Cell 12, 2109-2118, 2001.
65- SCOVASSI AL, PELLEGATA NS, DI STEFANO L, PADOVAN L, NEGRI C, PROSPERI E, RIVA F, CIOMEI M, RANZANI GN. - Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions.
Anticancer Res. 21: 2803-2808, 2001.
66- CAZZALINI O, LAZZE MC, IAMELE L, STIVALA LA, BIANCHI L, VAGHI P, CORNAGLIA A, CALLIGARO A, CURTI D, ALESSANDRINI A, PROSPERI E, VANNINI V. - Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes.
Biochem Pharmacol. 62: 893-902, 2001
67- RIVA F, ZUCO V, VINK AA, SUPINO R, PROSPERI E. - UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells.
Carcinogenesis. 22: 1971-1978, 2001.
68- SOMMI P, SAVIO M, STIVALA LA, SCOTTI C, MIGNOSI P, PROSPERI E, VANNINI V, SOLCIA E. – Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27kip1 protein expression.
Exp. Cell Res. 281: 128-139, 2002.
69- LAZZE MC, PIZZALA R, SAVIO M, STIVALA LA, PROSPERI E, BIANCHI L. – Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells.
Mutat. Res. 535: 103-115, 2003.
70- FROUIN I, MAGA G, DENEGRI M, RIVA F, SAVIO M, SPADARI S, PROSPERI E, SCOVASSI AI. - Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners.
J. Biol. Chem. 278: 39265-39268, 2003.
71- CAZZALINI O, PERUCCA P, RIVA F, STIVALA LA, BIANCHI L, VANNINI V, DUCOMMUN B, PROSPERI E.- p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition.
Cell Cycle 2 :596-603, 2003.
72- RIVA F, SAVIO M, CAZZALINI O, STIVALA LA, SCOVASSI IA, COX LS, DUCOMMUN B, PROSPERI E. - Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase δ or DNA ligase I.
Exp. Cell Res. 293: 357-67, 2004.
73- CAZZALINI O, PERUCCA P, VALSECCHI F, STIVALA LA, BIANCHI L, VANNINI V, PROSPERI E.- Intracellular localization of the cyclin-dependent kinase inhibitor p21(CDKN1A)-GFP fusion protein during cell cycle arrest.
Histochem. Cell Biol. 121 :377-381, 2004.
74- PERUCCA P, CAZZALINI O, MORTUSEWICZ O, NECCHI D, SAVIO M, NARDO T, STIVALA LA, LEONHARDT H, CARDOSO MC, PROSPERI E. - Spatiotemporal dynamics of p21CDKN1A protein recruitment to DNA-damage sites and interaction with proliferating cell nuclear antigen.
J Cell Sci. 119: 1517-1527, 2006
75- SCOVASSI AI, PROSPERI E.
Analysis of proliferating cell nuclear antigen (PCNA) associated with DNA excision repair sites in mammalian cells.
Methods Mol Biol. 314: 457-475, 2006
76- PROSPERI E.
The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work.
FASEB J. 20: 833-837, 2006.
77- CISTERNA B, NECCHI D, PROSPERI E, BIGGIOGERA M.
Small ribosomal subunits associate with nuclear myosin and actin in transit to the nuclear pores.
FASEB J. 20: 1901-1903, 2006.
78- SAVIO M, CERRI M, CAZZALINI O, PERUCCA P, STIVALA LA, PICHIERRI P, FRANCHITTO A, MEIJER L, PROSPERI E.
Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.
Cell Cycle. 5: 2153-2159, 2006.
79- LA REGINA G, EDLER MC, BRANCALE A, KANDIL S, COLUCCIA A, PISCITELLI F, HAMEL E, DE MARTINO G, MATESANZ R, DĶAZ JF, SCOVASSI AI, PROSPERI E, LAVECCHIA A, NOVELLINO E, ARTICO M, SILVESTRI R.
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
J Med Chem. 50: 2865-2874, 2007.
80- CAZZALINI O, PERUCCA P, SAVIO M, NECCHI D, BIANCHI L, STIVALA LA, DUCOMMUN B, SCOVASSI AI, PROSPERI E.
Interaction of p21(CDKN1A) with PCNA regulates the histone acetyltransferase activity of p300 in nucleotide excision repair.
Nucleic Acids Res. 36: 1713-1722, 2008.
81- DONĄ F, PROSPERI E, SAVIO M, COPPA T, SCOVASSI AI, MONDELLO C.
Loss of histone H2AX increases sensitivity of immortalized mouse fibroblasts to the topoisomerase II inhibitor etoposide.
Int J Oncol. 33: 613-621, 2008.
82- FRANCHITTO A, PIRZIO LM, PROSPERI E, SAPORA O, BIGNAMI M, PICHIERRI P.
Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway.
J Cell Biol. 183: 241-252, 2008.
83- PERUCCA P, CAZZALINI O, MADINE M, SAVIO M, LASKEY RA, VANNINI V, PROSPERI E, STIVALA LA.
Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence.
Cell Cycle 8: 105-114, 2009.
84- CISTERNA B, MALATESTA M, DIEKER J, MULLER S, PROSPERI E, BIGGIOGERA M.
An active mechanism flanks and modulates the export of the small ribosomal subunits.
Histochem Cell Biol. 131: 743-753, 2009.
85- SAVIO M, COPPA T, CAZZALINI O, PERUCCA P, NECCHI D, NARDO T, STIVALA LA, PROSPERI E.
Degradation of p21(CDKN1A) after DNA damage is independent of type of lesion, and is not required for DNA repair.
DNA Repair, 8: 778-785, 2009.
86- GIANSANTI V., CAMBONI T., PISCITELLI F, PROSPERI E, LA REGINA G, LAZZČ MC, SANTIN G, SILVESTRI R, SCOVASSI AI.
Study of the effects of a new pyrazolecarboxamide: Changes in mitochondria and induction of apoptosis.
Int J Biochem Cell Biol. 41: 1890-1898, 2009.
87- SAVIO M, COPPA T, BIANCHI L, VANNINI V, MAGA G, FORTI L, CAZZALINI O, LAZZČ MC, PERUCCA P, PROSPERI E, STIVALA LA.
The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol.
Int J Biochem Cell Biol. 41:2493-2502, 2009.
88- CAZZALINI O, SCOVASSI AI, SAVIO M, STIVALA LA, PROSPERI E.
Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response.
Mutat. Res. Rev Mutat. 704:12-20, 2010.
89- CAZZALINI O, DONĄ F, SAVIO M, TILLHON M, MACCARIO C, PERUCCA P, STIVALA LA, SCOVASSI AI, PROSPERI E. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.
DNA Repair 9:627-635, 2010.
90- PARKS M, TILLHON M, DONĄ F, PROSPERI E, SCOVASSI AI. 2-Methoxyestradiol: new perspectives in colon carcinoma treatment.
Mol Cell Endocrinol. 331:119-128, 2011.
91- GIANSANTI V, TILLHON M, MAZZINI G, PROSPERI E, LOMBARDI P, SCOVASSI AI.
Killing of tumor cells: A drama in two acts.
Biochem Pharmacol. 2011, in press